(Q48237362)

9 February 2018

title

The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. (English)

1 reference

9 February 2018

1 reference

7

1 reference

9 February 2018

John Christodoulou

10

1 reference

9 February 2018

author name string

Suzanne Schindeler

1

1 reference

9 February 2018

Suparna Ghosh-Jerath

2

1 reference

9 February 2018

Susan Thompson

3

1 reference

9 February 2018

Antonella Rocca

4

1 reference

9 February 2018

Pamela Joy

5

1 reference

9 February 2018

Allan Kemp

6

1 reference

9 February 2018

Kathryn Green

8

1 reference

9 February 2018

Bridget Wilcken

9

1 reference

9 February 2018

publication date

23 March 2007

1 reference

9 February 2018

Molecular Genetics and Metabolism

published in

1 reference

9 February 2018

volume

91

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

48-54

1 reference

9 February 2018

Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Benefits of mutation analysis and examination of brain phenylalanine levels in the management of phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Blood-brain phenylalanine relationships in persons with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

In vivo proton magnetic resonance spectroscopy in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Individual blood-brain barrier phenylalanine transport in siblings with classical phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Valine, isoleucine, and leucine. A new treatment for phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Brain phenylalanine concentration in the management of adults with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Transport mechanisms of the large neutral amino acid L-phenylalanine in the human intestinal epithelial caco-2 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

Large neutral amino acids in the treatment of phenylketonuria (PKU).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.02.002

10.1016/J.YMGME.2007.02.002

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17368065

1 reference

9 February 2018